Click here to go to the previous page
Treatment Planning for Prostate Cancer: Imaging (US CT MR) Immobilization, Fields, Tumor and Normal Tissue Doses
Program Code:
EDU505
Date:
Thursday, September 25, 2008
SPEAKER(S):
P. William Mclaughlin, Providence Cancer Center
Jeff Michalski, Vice Chairman and Director for Clinical Programs,
Washington University Medical Center
Dr. Michalski is the Vice Chair of the RTOG and a recognized expert in prostate cancer and clnical trials utilizing advanced technology. He has published numerous articles on prostate cancer, 3D conformal radiation therapy, IMRT and SBRT.
|
Howard Sandler, Chair, University of Michigan Medical Center
LEARNER OUTCOMES:
-
Discuss cancer control and normal tissue toxicity following IMRT techniques in terms of dose volume histogram analysis.
-
Discuss the current state of the art of IMRT techniques
-
Explain the radiographic anatomy of the prostate, seminal vesicles and normal juxtaposed and interposed structures